Anal fistula is a painful colorectal condition that affects hundreds of thousands of people worldwide
An anal fistula is an artificial tunnel between the rectum and skin of the buttocks that can develop due to an infected or blocked anal gland. If left untreated, an abscess may form, and the infection may travel through the patient’s sphincter muscle. Patients and their physicians are dissatisfied with current treatment options, which frequently result in inadequate or slow healing, a high risk of fecal incontinence, and repeat procedures.
A new technology for patients with anal fistula
QUALITY OF LIFE
Patients endure a poor quality of life, experiencing pain, suffering and discharge from the tract and related abscesses.
NO EFFECTIVE CURE
Patients and their physicians are dissatisfied with current treatment options, which are not effective for curing anal fistula.
Current treatments have generally poor results, with many carrying the risk of causing permanent incontinence, inadequate healing, and repeat surgeries
There are 64,000 annual surgical procedures performed to treat anal fistula in the U.S. alone.
The BioHealx™ is not currently approved in the United States or in the European Union.
WE ARE DEVELOPING NOVEL MINIMALLY INVASIVE TECHNOLOGIES TO TREAT COLORECTAL DISEASES
Signum Surgical is committed to developing innovative solutions to treat patients with colorectal diseases, starting with anal fistula. After a year of exploring the needs of gastrointestinal and colorectal care, Eoin Bambury and Moshe Zilversmit founded the company in 2016 as a spin-out of the National University of Ireland, Galway, BioInnovate programme. The company is headquartered in Galway, Ireland.
CO-FOUNDER / CEO
Medical device entrepreneur with over 12 years of experience in medical device development. Moshe released the world's first open source surgical device, which has been covered by Wired magazine and recognised by Discover Magazine as one of the top innovations of 2013.
CO-FOUNDER / CTO
Over 19 years of experience in the research and development of novel medical devices. Eoin has contributed to the development of six medical devices currently on the market and is a named author on 11 patent filings. Eoin was awarded 'Chartered Engineer of the Year 2012' by Engineers Ireland.
& BOARD CHAIRMAN
Jeff is an intellectual property specialist with more than 25 years of experience in early stage medtech companies. Jeff previously served as a Managing Partner at successful incubator The Foundry and holds a JD from the University of Washington and a BS in Mechanical Engineering from Stanford.
Alan brings more than 40 years of experience in the medical device industry. Alan is involved with multiple life science companies as a CEO and as a board member and was a Senior Advisor to Frazier Healthcare Partners. Alan is an expert in bioabsorbable materials and the inventor of Vicryl, an absorbable surgical suture.
Dr Collins is a leading expert in the medical technology sector and serves on the Board of Directors of several US and Irish life-science companies. A former Vice President of International Operations for Boston Scientific, where he served for 10 years, Dr Collins has held a number of senior executive positions in international life-science companies during his career.
STAY UP TO DATE WITH THE LATEST NEWS FROM SIGNUM SURGICAL
SUPPORT & INVESTORS
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848631
Developing Minimally Invasive Technologies to Treat Colorectal Diseases
1. Ommer A et al: Clinical practice guideline: Cryptoglandular anal fistula. Dtsch Arztebl Int 2011; 108(42): 707–13.